Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 305,667,944
- Total 13F shares
- 132,080,272
- Share change
- +13,688,192
- Total reported value
- $1,309,587,378
- Put/Call ratio
- 18%
- Price per share
- $9.89
- Number of holders
- 185
- Value change
- +$125,586,082
- Number of buys
- 113
- Number of sells
- 53
Report period
Q3 2022
Institutions
185
Top holders
10
ABCL full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00288U106
Recent filing periods:
Top shareholders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.4%
|
13,354,715
|
$142,227,000 | — | 30 Jun 2022 | |
| Capital World Investors |
13F
|
Company |
4.3%
|
13,038,357
|
$138,859,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.9%
|
11,825,332
|
$125,940,000 | — | 30 Jun 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
3.5%
|
10,822,530
|
$115,260,000 | — | 30 Jun 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.4%
|
10,450,180
|
$111,294,000 | — | 30 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.4%
|
4,180,768
|
$44,525,000 | — | 30 Jun 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
1.3%
|
4,105,095
|
$43,719,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
4,036,303
|
$42,987,000 | — | 30 Jun 2022 | |
| GUARDIAN CAPITAL ADVISORS LP |
13F
|
Company |
1.3%
|
3,836,414
|
$44,387,000 | — | 30 Jun 2022 | |
| Founders Fund VII Management, LLC |
13F
|
Company |
1.2%
|
3,773,530
|
$40,188,000 | — | 30 Jun 2022 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
1.1%
|
3,346,497
|
$35,640,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
3,194,309
|
$34,019,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.97%
|
2,956,644
|
$31,488,000 | — | 30 Jun 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.85%
|
2,593,958
|
$27,625,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
1,929,798
|
$20,552,000 | — | 30 Jun 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.57%
|
1,736,219
|
$18,491,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
1,419,429
|
$15,117,000 | — | 30 Jun 2022 | |
| Novo Holdings A/S |
13F
|
Company |
0.37%
|
1,126,915
|
$12,002,000 | — | 30 Jun 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.36%
|
1,102,520
|
$11,742,000 | — | 30 Jun 2022 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.36%
|
1,089,755
|
$11,606,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.29%
|
894,174
|
$9,523,000 | — | 30 Jun 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.25%
|
757,603
|
$8,068,000 | — | 30 Jun 2022 | |
| Casdin Capital, LLC |
13F
|
Company |
0.25%
|
750,000
|
$7,988,000 | — | 30 Jun 2022 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.24%
|
746,652
|
$7,952,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
727,922
|
$7,752,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
689,538
|
$7,343,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
684,311
|
$7,288,000 | — | 30 Jun 2022 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.22%
|
659,750
|
$7,026,000 | — | 30 Jun 2022 | |
| ArchPoint Investors |
13F
|
Company |
0.21%
|
630,326
|
$6,713,000 | — | 30 Jun 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.17%
|
513,710
|
$5,472,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
479,001
|
$5,101,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
457,290
|
$4,871,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
410,104
|
$4,368,000 | — | 30 Jun 2022 | |
| Founders Fund Growth Management, LLC |
13F
|
Company |
0.13%
|
407,017
|
$4,334,000 | — | 30 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.13%
|
395,332
|
$4,210,000 | — | 30 Jun 2022 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.13%
|
393,776
|
$4,194,000 | — | 30 Jun 2022 | |
| Aberdeen Group plc |
13F
|
Company |
0.12%
|
375,062
|
$3,918,000 | — | 30 Jun 2022 | |
| Gruss & Co., LLC |
13F
|
Company |
0.12%
|
363,778
|
$3,874,000 | — | 30 Jun 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.12%
|
354,476
|
$4,554,309 | — | 30 Jun 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.11%
|
337,650
|
$3,471,000 | — | 30 Jun 2022 | |
| NORGES BANK |
13F
|
Company |
0.09%
|
285,369
|
$3,039,180 | — | 30 Jun 2022 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.09%
|
281,729
|
$3,000,414 | — | 30 Jun 2022 | |
| Jump Financial, LLC |
13F
|
Company |
0.09%
|
272,612
|
$2,903,000 | — | 30 Jun 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
265,553
|
$2,828,000 | — | 30 Jun 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.09%
|
262,503
|
$2,796,000 | — | 30 Jun 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
241,228
|
$2,569,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
234,487
|
$2,497,000 | — | 30 Jun 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.08%
|
233,100
|
$2,483,000 | — | 30 Jun 2022 | |
| Jefferies Group LLC |
13F
|
Company |
0.06%
|
197,161
|
$2,099,765 | — | 30 Jun 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
196,406
|
$2,092,000 | — | 30 Jun 2022 |
Institutional Holders of AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) as of Q3 2022
As of 30 Sep 2022,
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) was held by
185 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
132,080,272 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, BlackRock Inc., Voya Investment Management LLC, Voya Investment Management LLC, BAKER BROS. ADVISORS LP, Capital World Investors, ORBIMED ADVISORS LLC, HARVARD MANAGEMENT CO INC, CREDIT SUISSE AG/, and Founders Fund VII Management, LLC.
This page lists
185
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
160
Q3 2022 holders
185
Holder diff
25
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.